ProZinc ™ (protamine zinc recombinant human insulin)

• Home
• |
• Terms of use
• |
• Privacy
• |
• Site map
• |
• Contact us

PROZINC is a trademark of Boehringer Ingelheim Vetmedica, Inc.
© 2009 Boehringer Ingelheim Vetmedica, Inc.

As a class, the use of any insulin when regulating a diabetic cat may be associated with side effects. The most common side effect reported in field studies was hypoglycemia. This is usually mild (lethargy, weak, trembling, uncoordinated, groggy, dazed), but may be serious and life-threatening (seizures, coma). If side effects occur, cat owners should contact their veterinarian immediately. Cats should be evaluated for pre-existing conditions and currently prescribed medications prior to treatment with PROZINC. Routine monitoring (blood parameters such as glucose and fructosamine and clinical signs) is essential to maintain a regulated cat. PROZINC insulin is contraindicated during episodes of hypoglycemia. Please refer to the package insert for complete product information.